¿øÀº¼ö
¼Ò
¼Ó
: ºÐ´çÂ÷º´¿ø
Àü¹®ºÐ¾ß : ¿ì¿ï,ºÒ¾È,½ºÆ®·¹½º,Á¾¾çÁ¤½ÅÀÇÇÐ
Á÷
ˤ
: Á¶±³¼ö
¸Þ
ÀÏ
:
ºñ°ø°³
Àü
È
:
1577-4488
ÆÑ
½º
:
ÁÖ
¼Ò
:
°æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßžµ¿ 351¹øÁö
ȨÆäÀÌÁö:
ÅǸ޴º
ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£
±¸ºÐ
Á¦¸ñ
´Ù¿î·Îµå
40
ÇØ¿Ü
Interaction effects of oxytocin receptor gene polymorphism and depression on hippocampal volume(2018)
39
ÇØ¿Ü
A review on inflammatory cytokine-induced alterations of the brain as potential neural biomarkers in post-traumatic stress disorder.(2018)
38
ÇØ¿Ü
An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms.(2017)
37
ÇØ¿Ü
The association between substance P and white matter integrity in medication-naive patients with major depressive disorder.(2017)
36
ÇØ¿Ü
The influence of stress on neuroinflammation and alterations in brain structure and function in major depressive disorder.(2017)
35
ÇØ¿Ü
Vesicular monoamine transporter 1 gene polymorphism and white matter integrity in major depressive disorder.(2017)
34
ÇØ¿Ü
Influence of FKBP5 polymorphism and DNA methylation on structural changes of the brain in major depressive disorder.(2017)
33
ÇØ¿Ü
Regional cortical thinning of the orbitofrontal cortex in medication-naïve female patients with major depressive disorder is not associated with MAOA-uVNTR polymorphism.(2016)
32
ÇØ¿Ü
Stress, the Autonomic Nervous System, and the Immune-kynurenine Pathway in the Etiology of Depression.(2016)
31
ÇØ¿Ü
Association between reduced white matter integrity in the corpus callosum and serotonin transporter gene DNA methylation in medication-naive patients with major depressive disorder.(2016)
1
2
3
4
Copyright ¨Ï chamc, All rights reserved.
ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à
Àüȹ®ÀÇ
°³²Â÷º´¿ø 02.3468.3000
ºÐ´çÂ÷º´¿ø 031.780.5000
Â÷¿ò 02.3015.5300
±¸¹ÌÂ÷º´¿ø 054.450.9700
´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
°³²°ÇÁø¼¾ÅÍ 02.2191.3900
ºÐ´çÁ¾ÇÕ°Ç°ÁõÁø¼¾ÅÍ 031.780.5940
½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729